| *Program subject to change* |
| 29/09/2016 - Thursday | |||||
 12:30 pm - 1:45 pm | Registration | ||||
| 1:45 pm - 4:00 pm | Opening Plenary Central Room A Chairperson: Carla Treloar, Professor, Centre for Social Research in Health, UNSW, Australia Chairperson: Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia | ||||
| 1:45 pm - 1:55 pm | Welcome to Country Central Room A Craig Williams, Traditional Owner | ||||
| 1:55 pm - 2:00 pm | Committee Welcome Central Room A Krispin Hajkowicz, Senior Lecturer, Infectious Diseases, University of Queensland, Australia | ||||
| 2:00 pm - 2:10 pm | Government Representative Welcome Central Room A The Hon Dr David Gillespie MP, Assistant Minister for Rural Health | ||||
| 2:10 pm - 2:20 pm | My Experience Living with Hepatitis C Central Room A Scott | ||||
| 2:20 pm - 2:30 pm | My Experience Living with Hepatitis B Central Room A Linh Nguyen | ||||
| 2:30 pm - 3:00 pm | Treating Epidemics with Low-Cost Generics Central Room A Andrew Hill, Senior Visiting Research Fellow, Pharmacology Department Liverpool University Presentation | ||||
| 3:00 pm - 3:30 pm | The Future of Hep C Care for People Who Use Drugs: Lessons from a Community-Based, Harm Reduction, Client-Driven Program in Toronto, Canada Central Room A Zoe Dodd, co-founder and Program Coordinator, Toronto Community Hep C Program, Toronto, Canada Abstract | ||||
| 3:30 pm - 4:00 pm | The New HCV treatment Era in Australia: Early Lessons Central Room A Greg Dore, Head, Kirby Institute, UNSW, Australia | ||||
| 4:00 pm - 4:30 pm | Afternoon Tea Exhibition Hall, Hall 1 | ||||
| 4:30 pm - 6:00 pm | Cross Track Session: How can we provide better services for people with viral hepatitis? (Models of Care) Central Room A Chairperson: Emma Day, INHSU Program Manager, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, Sydney, Australia Chairperson: Krispin Hajkowicz, Senior Lecturer, Infectious Diseases, University of Queensland, Australia | Cross Track Session: International Revolution Room 5 Chairperson: Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia Chairperson: Lisa Maher, Program Head and NHMRC Senior Research Fellow, The Kirby Institute, UNSW, Australia | Cross Track Session: Viral Hepatitides Session Room 6 Chairperson: David Anderson, Deputy Director, Burnet Institute, Melbourne, Australia Chairperson: Margaret Littlejohn, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia | ||
| | 4:30pm - 4:45pm Report back from MOC Satellite Central Room A Krispin Hajkowicz, Senior Lecturer, Infectious Diseases, University of Queensland, Australia Presentation | 4:30pm - 4:35pm Introduction Room 5 Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia Presentation | 4:30pm - 5:00pm Hepatitis A Outbreaks in Australia Room 6 Scott Bowden, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia | ||
| | 4:45pm - 5:00pm Liver Disease Burden and Clinical Follow-Up during a Liver Health Promotion Intervention Integrating Non-Invasive Liver Disease Screening in Drug and Alcohol Settings: The Liverlife Study Central Room A Jason Grebely, Associate Professor, The Kirby Institute, UNSW, Australia | 4:35pm - 4.50pm Australia’s Progress Towards the National Hepatitis Strategy Targets Room 5 John Kaldor, Professor and Program Head, Kirby Institute, NSW, Australia | |||
| | 5:00pm - 5:15pm Quihn Treatment Management Program: An Evolving HCV Treatment Model for People who Inject Drugs - a Community Prescribing Model in Queensland, Australia Central Room A Nik Alexander, Senior Program Manager - Harm Reduction Services, Queensland Injectors Health Network (QuIHN), Australia | 4:50pm - 5:05pm UNGASS and Beyond Room 5 Kathryn Leafe, Executive Director , Needle Exchange Services Trust, New Zealand Presentation | 5:00pm - 5:30pm - Hepatitis Delta Virus in Australia Room 6 Kathy Jackson, Senior Scientist, Victorian Infectious Diseases Reference Laboratory, Doherty Institute, Australia | ||
| | 5:05pm - 5:20pm International viral hepatitis responses for indigenous peoples Room 5 James Ward, Head, Infectious Diseases Research Aboriginal and Torres Strait Islander Health, SAHMRI, Australia | ||||
| | 5:15pm - 5:30pm One Size Does Not Fit All: Two Hepatitis B Outreach Testing Models Central Room A Marina Suarez, Health Promotion Officer, Multicultural HIV and Hepatitis Service, Australia | 5:20pm - 5:35pm WHO and hepatitis: what the elimination agenda means for the Region (via Skype) Room 5 Nick Walsh MD PhD, Medical Officer | Viral Hepatitis, World Health Organization, Philippines | |||
| | 5:30pm - 6:00pm Panel Discussion Central Room A Krispin Hajkowicz, Senior Lecturer, Infectious Diseases, University of Queensland, Australia Jason Grebely, Associate Professor, The Kirby Institute, UNSW, Australia Nik Alexander, Senior Program Manager - Harm Reduction Services, Queensland Injectors Health Network (QuIHN), Australia Marina Suarez, Health Promotion Officer, Multicultural HIV and Hepatitis Service, Australia Zoe Dodd, co-founder and Program Coordinator, Toronto Community Hep C Program, Toronto, Canada Emma Day, INHSU Program Manager, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, Sydney, Australia | 5:35pm - 6:00pm Panel Discussion Room 5 Rebecca Guy, Associate Professor, Kirby Institute, UNSW, Australia James Ward, Head, Infectious Diseases Research Aboriginal and Torres Strait Islander Health, SAHMRI, Australia Kathryn Leafe, Executive Director , Needle Exchange Services Trust, New Zealand Nick Walsh MD PhD, Medical Officer | Viral Hepatitis, World Health Organization, Philippines Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia Lisa Maher, Program Head and NHMRC Senior Research Fellow, The Kirby Institute, UNSW, Australia | 5:30pm - 6:00pm - Update on Hepatitis E in Australia Room 6 David Siebert, Infectious Diseases Physician and microbiologist, Princess Alexandra Hospital, Brisbane | ||
| 6:00 pm - 8:00 pm | Welcome Reception and Poster Viewing Exhibition Hall, Hall 1 | ||||
| 6:10 pm - 6:40 pm | Launch of the Kirby and CSRH Surveillance Reports Central Room A Greg Dore, Head, Kirby Institute, UNSW, Australia Carla Treloar, Professor, Centre for Social Research in Health, UNSW, Australia James Ward, Head, Infectious Diseases Research Aboriginal and Torres Strait Islander Health, SAHMRI, Australia | ||||
| 30/09/2016 - Friday | ||||
| 6.30 am | Registration Opens | |||
| 7:00 am - 8:45 am | BMS Breakfast Satellite Session - HCV Elimination by 2026. Australia leads the world Central Room A Moderator: Dr Norman Swan, ABC Health Report | |||
| 7:00 am - 8:45 am | Panellists Central Room A Brent Allan, Living Positive Victoria, Melbourne, Australia Joanne Morgan, Australian Hepatology Association & Royal Adelaide Hospital, Adelaide, Australia Levinia Crooks, Adjunct Associate Professor, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, Sydney, Australia Mark O’Reilly, Dr, Prahran Market Clinic, Melbourne, Australia Greg Dore, Head, Kirby Institute, UNSW, Australia Andrew Lloyd, Professor, Kirby Institute, Prince of Wales Hospital, and Justice Health & Forensic Mental Health Network, New South Wales, Australia Helen Tyrrell, CEO, Hepatitis Australia, ACT, Australia | |||
| 9:00 am - 10:30 am | Plenary 2 Central Room A Chairperson: Scott Bowden, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia Chairperson: Gail Matthews, A/Professor, Kirby Institute, UNSW, Australia | |||
| 9:00 am - 9:30 am | Hepatitis Transmission and Prevention: Exploring the Role that the Law Plays in Shaping Blood Borne Virus Epidemics Central Room A Kate Seear, ARC DECRA Fellow and Senior Lecturer in Law, Monash University, Victoria, Australia Abstract | |||
| 9:30 am - 10:00am | Deciphering Host Range Restrictions of Human Hepatitis Viruses Central Room A Alex Ploss, PhD, Assistant Professor, Princeton University, USA Abstract | |||
| 10:00 am - 10:30 am | Recommendations for the Management of Hepatitis C Virus Infection: Australian and International Guidelines Central Room A Alex Thompson, Director of Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia Presentation | |||
| 10:30 am - 11:00 am | Morning Tea Exhibition Hall, Hall 1 | |||
| 11:00 am - 12:30 pm | Epidemiology, Public Health & Prevention - Epidemiology and natural history of hepatitis B & C Central Room A Chairperson: Jess Howell, NHMRC Post Doctoral research fellow, Burnet Institute, Australia Chairperson: Peter Higgs, Senior Lecturer, La Trobe University, Melbourne, Australia | Community & Social Research - Good community responses to priority populations Central Room C Chairperson: Christian Vega, Policy & Research Officer, AIVL, Canberra, Australia Chairperson: Elena Cama, Research Associate, Centre for Social Research in Health at UNSW, Australia | Clinical - Developments in HBV Treatment and Management Room 5 Chairperson: Simone Strasser, Hepatologist, Royal Prince Alfred Hospital Chairperson: Paul Clark, Gastroenterologist, Queensland, Australia | Community & Social Research - Culture and engagement - CALD & Indigenous Room 6 Chairperson: Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia Chairperson: Helen Tyrrell, CEO, Hepatitis Australia, ACT, Australia |
| 11:00 am - 11:15 am | Prevalence of Hepatitis C among Aboriginal and Torres Strait Islander Australians: A Meta-Analysis Central Room A Dr Mary Ellen Harrod, Chief Executive Officer , NSW Users and AIDS Association, Australia | Advocates in Action: The work of Hepatitis Victoria Community Advocates Central Room C Ross Williams, Community Advocate, Hepatitis Victoria, Australia Nafisa Yussf, Community Advocate , Hepatitis Victoria, Australia | 11:00am - 11:20am HBV Treatment: Past, Present and the Future Room 5 Scott Bowden, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia Presentation | Engaging Diverse Communities in the Response to Hepatitis B: The Hepatitis B Community Alliance NSW Room 6 Marina Suarez, Health Promotion Officer, Multicultural HIV and Hepatitis Service, Australia |
| 11:15 am - 11:30 am | Hepatic Fibrosis and Quality of Life in People Who Inject Drugs with Hepatitis C Virus Central Room A Stelliana Goutzamanis, student (honours), The Burnet Institute, Australia | Experiences of Diagnosis, Care and Treatment among Aboriginal People Living with Hepatitis C Central Room C Loren Brener, Senior Research Fellow, Centre for Social Research in Health, Australia | 11:20am - 11:30am Distance and Disparity Room 5 Jane Davies, Senior Clinical Research Fellow, Menzies School of Health Research, Australia | “You Know In the Community When They Heard of Something and Then You Can’t Even Be With Them”: Lived Experiences of Chronic Hepatitis B among South Sudanese in Australia Room 6 William Mude, PhD Candidate, Australian Research Centre for Sex, Health and Society; La Trobe University, Australia |
| 11:30 am - 11:45 am | Trends in Hepatocellular Carcinoma, Victoria, Australia, 2004-2013 Central Room A Kylie Carville, Epidemiologist, WHO Collaborating Centre for Viral Hepatitis VIDRL, Doherty Institute for Infection and Immunity, Australia | Peer Support Increases Access to Hepatitis C Treatment to Care in Drug and Alcohol Settings Central Room C Yvonne Samuel, Peer Support Work Coordinator, NSW Users and AIDS Association, Australia | 11:30am - 11:40am - Challenges in HBV Treatment and Management Room 5 Jacqui Richmond, Research Fellow / Clinical Nurse Consultant, La Trobe University / Melbourne Health, Australia Presentation | Vietnamese Understandings and Responses to Chronic Hepatitis B Room 6 Roslyn Le, Research Fellow, Australian Research Centre in Sex, Health and Society, La Trobe University, Australia |
| 11:45 am - 12:00 pm | Trends in Hepatocellular Carcinoma among People with a HBV or HCV Notification in New South Wales, Australia between 2000 and 2014 Central Room A Reem Waziry, PhD candidate, The Kirby institute-UNSW, Australia | The Prison Economy of Needles and Syringes: What Opportunities Exist for BBV Risk Reduction When Prices are so High? Central Room C Carla Treloar, Professor, Centre for Social Research in Health, UNSW, Australia | 11:40am - 12:30pm Case Discussion Room 5 Scott Bowden, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia Jane Davies, Senior Clinical Research Fellow, Menzies School of Health Research, Australia Jacqui Richmond, Research Fellow / Clinical Nurse Consultant, La Trobe University / Melbourne Health, Australia Moderator: Simone Strasser, Hepatologist, Royal Prince Alfred Hospital Moderator: Paul Clark, Gastroenterologist, Queensland, Australia | Liverzone Room 6 Hande Noyan, Care and Support Women's Health Coordinator, Northern Territory AIDS and Hepatitis Council, Australia Presentation |
| 12:00 pm - 12:15 pm | Hepatitis B Prevalence in Communities in the Eastern African region: A Systematic Literature Review Central Room A William Mude, PhD Candidate, Australian Research Centre for Sex, Health and Society; La Trobe University, Australia | A Community Collaboration for an Improved Policy Response to BBVS in Australian Prisons Central Room C Kevin Marriott, Policy Officer, Hepatitis Australia, Australia | Deadly Grandmothers; Proper Way Partnerships, Supporting Elders Working with Young People in Community Room 6 Jodie Walton, BBV & STI Education Project Officer, Hepatitis Queensland, Australia | |
| 12:15 am - 12: 30 am | Discussion Central Room A | Discussion Central Room C | Discussion Room 6 | |
| 12:30 pm - 1:30 pm | Lunch Exhibition Hall, Hall 1 | |||
| 12:50 pm - 1:15pm | AHA Adherance Guidelines Launch Room 5 | |||
| 12:50 pm - 1:15pm | Centre for Social Research in Health - Community Consultation Room 6 | |||
| 1:30 pm - 2:45 pm | Epidemiology, Public Health & Prevention - Informing prevention strategies in hepatitis C priority populations Central Room A Chairperson: Mark Stoove, Associate Professor , Burnet Institute, Australia Chairperson: Lisa Maher, Program Head and NHMRC Senior Research Fellow, The Kirby Institute, UNSW, Australia | Community & Social Research - Enhancing Testing and Treatment Central Room C Chairperson: Yvonne Drazic, PhD candidate, James Cook University, Australia Chairperson: Janette Medforth, The Hepatitis Foundation of New Zealand, New Zealand | Clinical - Improving outcomes for antiviral therapy for Hepatitis B Room 5 Chairperson: Joanne Morgan, Australian Hepatology Association & Royal Adelaide Hospital, Adelaide, Australia Chairperson: Graeme MacDonald, Senior Staff Specialist, PA-Southside Clinical School, The University of Queensland, Princess Alexandra Hospital, Australia Presentation | Basic Science - HBV Room 6 Chairperson: Peter Revill, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory (VIDRL), Doherty Institute, Victoria, Australia Chairperson: Scott Bowden, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia |
| 1:30 pm - 1:45 pm | Associations with Hepatitis C Virus Infection among Men Who Have Sex with Men in Vietnam Central Room A Nghia Khuu, Head of HIV/AIDS Unit , The Pasteur Institute, Ho Chi Minh City, Vietnam | Qualitative Evaluation of the Decisions and Experiences of People Who Inject Drugs Who Received a Liver Disease Assessment as Part of a Liver Health Promotion Campaign: The Liverlife Study Central Room C Carla Treloar, Professor, Centre for Social Research in Health, UNSW, Australia | Yes We Can! Optimising Treatment and Management of Chronic Hepatitis B Based on a Disease Registry Room 5 Ximena Masgoret, Research Assistant, Cancer Council, NSW, Australia | HBV Core Promoter Mutants Activate Pi3k/AKT Signalling In Cell Culture, Promoting Hepatocarcinogenesis Room 6 Anis Khan, Postdoctoral Scientist, The Westmead Institute for Medical Research, Australia |
| 1:45 pm - 2:00 pm | Stable Incidence of Hepatitis C Virus Infection among People with a History of Injecting Drug Use in an Australian Prison Setting, 2005-2014: The HITS-P Study Central Room A Evan Cunningham, PhD Candidate, Kirby Institute - UNSW, Australia | Hepatitis B Testing and Diagnosis Experiences of People with Hepatitis B and Health Professionals Central Room C Jacqui Richmond, Research Fellow / Clinical Nurse Consultant, La Trobe University / Melbourne Health, Australia | The ‘B in It’ Programme - Community Based Care of Chronic Hepatitis B Patients Using a Novel Online Clinical Guide Room 5 Debra O'Leary, Project Officer, St Vincent's Hospital Melbourne, Australia | Viral Kinetic are Significantly Different In Basal Core Promoter and Precore Variants of Hepatitis B Room 6 Zina Valaydon, Gastroenterologist & PhD Fellow, St Vincent's Hospital and VIDRL, Australia |
| 2:00 pm - 2:15 pm | Modelling Hepatitis C Virus Transmission in a High-Risk Incarcerated Population Central Room A Neil Bretana, PhD student, UNSW, Australia | Hepatitis B Clinical Specialists: Responding to Cultural Diversity Central Room C Jack Wallace, Research Fellow, Australian Research Centre in Sex, Health and Society, Australia | Supporting Patients with Chronic Hepatitis B: Improving the Patient Experience through a Shared Model of Care Room 5 Kristen Stone, Clinical Nurse Specialist, Storr Liver Centre, Westmead Hospital, Australia | Deep Sequencing Shows that the Presence of HBV BCP/Pc Variants Reduces the Rate of HBSAG Loss among HBEAG-Positive CHB Patients Treated with Long-Term Tenofovir DF Therapy Room 6 Margaret Littlejohn, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia |
| 2:15 pm - 2:30 pm | Hepatitis C Virus Exposure, Infection and Associated Risk Behaviours in Two Maximum-Security Prisons in New South Wales, Australia Central Room A Behzad Hajari, Associate Lecturer, UNSW, Australia | Engaging Affected Communities in Treatment Advocacy Campaigning Central Room C David Pieper, Campaigns Coordinator, Hepatitis NSW, Australia | Viral Outcomes in Patients with Chronic Hepatitis B and Correlation with Pharmacy Adherence Measures Room 5 Nicole Allard, General Practitioner, Doherty, Melbourne, Australia | Molecular Epidemiology of Hepatitis Delta Virus in Oceania Room 6 Kathy Jackson, Senior Scientist, Victorian Infectious Diseases Reference Laboratory, Doherty Institute, Australia |
| 2:30 pm - 2:45pm | Discussion Central Room A | Discussion Central Room C | Concordance between Missed Days of Hepatitis B Virus Anti-Viral Therapy and Virological Breakthrough Room 5 Suzanne Sheppard-Law, Senior Research Fellow, University of Technology Sydney/Sydney Children's Hospital Network, Australia | An Immunochromatographic Test for Measurement of Alanine Aminotransferase (ALT) at Point of Care Room 6 David Anderson, Deputy Director, Burnet Institute, Melbourne, Australia |
| 2:45 pm - 3:05 pm | Afternoon Tea Exhibition Hall, Hall 1 | |||
| 3:05 pm - 4:25 pm | Epidemiology, Public Health & Prevention - Burden of Hepatitis B and Hepatitis C infections globally and in Australia Central Room A Chairperson: Nicole Allard, General Practitioner, Doherty, Melbourne, Australia Chairperson: Jason Grebely, Associate Professor, The Kirby Institute, UNSW, Australia | Community & Social Research - Stigma and other barriers to healthcare in the lives of people who inject drugs and those living with Hepatitis C Central Room C Chairperson: Kate Seear, ARC DECRA Fellow and Senior Lecturer in Law, Monash University, Victoria, Australia Chairperson: Christian Vega, Policy & Research Officer, AIVL, Canberra, Australia | Clinical - Difficult Scenarios for HCV management Room 5 Chairperson: Graeme MacDonald, Senior Staff Specialist, PA-Southside Clinical School, The University of Queensland, Princess Alexandra Hospital, Australia Chairperson: Krispin Hajkowicz, Senior Lecturer, Infectious Diseases, University of Queensland, Australia | Basic Science - Is elimination of hepatitis C possible without a vaccine? Room 6 Chairperson: Tanya Applegate, Senior Lecturer, The Kirby Institute, UNSW, Australia Chairperson: Heidi Drummer, Laboratory Head, Burnet Institute, Australia |
| | 3:05pm - 3:10pm Launch of the Third National Hepatitis B Mapping Report Central Room A Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia Presentation | 3:05pm - 3:20pm Stigma among People Living With Hepatitis C and People Who Inject Drugs in Australia Central Room C Elena Cama, Research Associate, Centre for Social Research in Health at UNSW, Australia | 3:05pm - 3:15pm Difficult scenarios for HCV management Room 5 Ed Gane, Professor of Medicine, University of Auckland, New Zealand Presentation | 3:05pm - 3:35pm Gaps in Experimental Systems Required for Preclinical Testing of HCV Vaccine Candidates Room 6 Alex Ploss, PhD, Assistant Professor, Princeton University, USA |
| | 3:10pm - 3:25pm Global Burden Central Room A Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia Presentation | 3:20pm - 3:35pm Beyond the ‘Empty Warehouse’: Exploring Barriers and Facilitators for Reaching Those ‘Next In Line’ For the New HCV Treatments Central Room C Angella Duvnjak, Program Manager, Australian Injecting and Illicit Drug Users League, Australia | 3:15pm - 3:25pm Difficult scenarios for HCV management Room 5 Olivia Cullen, Clinical nurse consultant , Royal Brisbane and Women’s Hospital, Australia | 3:35pm - 4:00pm Modelling HCV Elimination: Is it Achievable What Role Would a Vaccine Play Room 6 Nick Scott, Econometrician , Burnet Institute, Australia Presentation |
| | 3:25pm - 3:40pm HCC epidemiology in Australia- A tale of two cities Central Room A Paul Clark, Gastroenterologist, Queensland, Australia | 3:35pm - 3:50pm Stigma, Discrimination & People Who Inject Drugs: Genuine access to new hepatitis C treatments Central Room C Yvonne Samuel, Peer Support Work Coordinator, NSW Users and AIDS Association, Australia Presentation | 3:25pm - 3:35pm Difficult scenarios for HCV management Room 5 Gail Matthews, A/Professor, Kirby Institute, UNSW, Australia | 4:00pm - 4:25pm Myanmar global perspective on DAAs and vaccines Room 6 Mark Stoove, Associate Professor , Burnet Institute, Australia Presentation |
| | 3:40pm - 3:55pm Estimating populations PWID Central Room A Sarah Larney, Senior Research Fellow, National Drug and Alcohol Research Centre, University of New South Wales, Australia Presentation | 3:50pm - 4:05pm Reducing Barriers | NZ experiences Central Room C Kathryn Leafe, Executive Director , Needle Exchange Services Trust, New Zealand | 3:35pm - 4:25pm Case Discussion - Panel Room 5 Moderator: Graeme MacDonald, Senior Staff Specialist, PA-Southside Clinical School, The University of Queensland, Princess Alexandra Hospital, Australia Moderator: Krispin Hajkowicz, Senior Lecturer, Infectious Diseases, University of Queensland, Australia Ed Gane, Professor of Medicine, University of Auckland, New Zealand Olivia Cullen, Clinical nurse consultant , Royal Brisbane and Women’s Hospital, Australia Greg Dore, Head, Kirby Institute, UNSW, Australia | |
| | 3:55pm - 4:10pm Estimating the burden of hepatitis B infection in Aboriginal and Torres Strait Islander People Central Room A Jane Davies, Senior Clinical Research Fellow, Menzies School of Health Research, Australia Presentation | 4:05pm - 4:25pm- Panel Discussion Central Room C Kate Seear, ARC DECRA Fellow and Senior Lecturer in Law, Monash University, Victoria, Australia Christian Vega, Policy & Research Officer, AIVL, Canberra, Australia Elena Cama, Research Associate, Centre for Social Research in Health at UNSW, Australia Angella Duvnjak, Program Manager, Australian Injecting and Illicit Drug Users League, Australia Kathryn Leafe, Executive Director , Needle Exchange Services Trust, New Zealand Yvonne Samuel, Peer Support Work Coordinator, NSW Users and AIDS Association, Australia | ||
| | 4:10pm - 4:25pm Panel Discussion Central Room A Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia Sarah Larney, Senior Research Fellow, National Drug and Alcohol Research Centre, University of New South Wales, Australia Margaret Hellard, Professor, Burnet Institute, Melbourne, VIC, Australia Melanie Eagle, Chief Executive Officer , Hepatitis Victoria, VIC, Australia Yvonne Drazic, PhD candidate, James Cook University, Australia Nicole Allard, General Practitioner, Doherty, Melbourne, Australia Jason Grebely, Associate Professor, The Kirby Institute, UNSW, Australia Paul Clark, Gastroenterologist, Queensland, Australia Jane Davies, Senior Clinical Research Fellow, Menzies School of Health Research, Australia | |||
| 4:30 pm - 5:00 pm | Plenary 3 Central Room A Chairperson: Helen Tyrrell, CEO, Hepatitis Australia, ACT, Australia Chairperson: Susan Hay, Acting Chief Executive Officer, The Hepatitis Foundation of NZ,New Zealand | |||
| 4:30 pm - 5:00 pm | Global Strategies are Required to Cure and Eliminate HBV Central Room A Peter Revill, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory (VIDRL), Doherty Institute, Victoria, Australia Abstract | |||
| 5:00 pm - 5:30 pm | We have Perfectovir - do we need anything else? Central Room A Ed Gane, Professor of Medicine, University of Auckland, New Zealand | |||
| 5:00 pm - 10:30 pm | Conference Dinner - Depart from Gold Coast Convention & Exhibition Centre McLarens Landing | |||
| 01/10/2016 - Saturday | ||||
| 7:00 am | Registration Opens | |||
| 7:30 am - 9:15 am | Curing HCV - Leave no Patient Behind - AbbVie Breakfast Satellite Session Central Room A Chairperson: Simone Strasser, Hepatologist, Royal Prince Alfred Hospital | |||
| 8:00 am - 8:05 am | Introduction Central Room A Simone Strasser, Hepatologist, Royal Prince Alfred Hospital | |||
| 8:05 am - 8:25 am | Curing the Co-infected in the Community Central Room A Dr Phillip Read, Kirketon Road Centre, Australia | |||
| 8:25am - 8:45 am | Taking Treatment to the Patient – Beyond traditional settings Central Room A Jana Van der Jagt, Dr, Port Macquarie Hospital, Australia | |||
| 8:45am - 9:05 am | The Legacy of Resistance Associated Substitutions Central Room A Alex Thompson, Professor, Australian Liver Association & St Vincent’s Hospital, Melbourne, Australia | |||
| 9:05 am - 9:10 am | Closing Remarks Central Room A Simone Strasser, Hepatologist, Royal Prince Alfred Hospital | |||
| 9:30 am - 11:00 am | Epidemiology, Public Health & Prevention - Strategies to enhance the Hepatitis B and C Care Cascades Central Room A Chairperson: Andrew Hill, Senior Visiting Research Fellow, Pharmacology Department Liverpool University Chairperson: Lisa Maher, Program Head and NHMRC Senior Research Fellow, The Kirby Institute, UNSW, Australia | Community & Social Research -Communities responding to hepatitis B: barriers, enablers and experiences Central Room C Chairperson: Jack Wallace, Research Fellow, Australian Research Centre in Sex, Health and Society, Australia Chairperson: Enaam Oudih, Practice Manager, Multicultural Services,Manager BBV programs, Manager Multicultural Gambling Health Service, Relationships Australia, SA, Australia | Clinical - Fibrosis Assessment Room 5 Chairperson: Ken Koh, GP, Holdsworth House, Australia Jeremy Hayllar, Clinical Director, Metro North Mental Health - Alcohol and Drug Service, Brisbane, Australa | Basic Science - Eliminate hepatitis B: A multi-pronged approach is required Room 6 Chairperson: Heidi Drummer, Laboratory Head, Burnet Institute, Australia Chairperson: Mark Douglas, Associate Professor, University of Sydney, Australia |
| | 9:30am - 9:45am Interventions to Enhance Hep C cascade Central Room A Jason Grebely, Associate Professor, The Kirby Institute, UNSW, Australia Presentation | 9:30am - 10:00am Cross Cultural Community Engagement Matters Central Room C Enaam Oudih, Practice Manager, Multicultural Services,Manager BBV programs, Manager Multicultural Gambling Health Service, Relationships Australia, SA, Australia Presentation | 9:30am - 10:00am Non-Invasive Assessment of Liver Fibrosis Room 5 Joseph Doyle, Co-Head, Hepatitis Research, Burnet Institute, Australia | 9:30am - 10:00am Global Strategies are required to cure and eliminate HBV Room 6 Peter Revill, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory (VIDRL), Doherty Institute, Victoria, Australia |
| | 9:45am - 10:00am Interventions to Enhance Hep B Cascade Central Room A Jennifer MacLachlan, Epidemiologist, WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, Australia Presentation | 10:00am - 10:30am Deadly Grandmothers: Hepatitis QLD Central Room C Jodie Walton, BBV & STI Education Project Officer, Hepatitis Queensland, Australia | 10:00am - 10:30am Community Assessment of Fibrosis in Primary Care and Rural Settings Room 5 Annie Balcomb, General Practitioner, Prince St Medical Practice, Australia Presentation | 10:00am - 10:30am Nucleos(t)ide analogues for chronic hepatitis B: Cessation of treatment Room 6 Alex Thompson, Director of Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia Presentation |
| | 10:00am - 10:10am The Use of Surveillance Systems to Improve Diagnosis and Testing tor Hepatitis B and C Central Room A Margaret Hellard, Professor, Burnet Institute, Melbourne, VIC, Australia Presentation | 10:30am - 11:00am Panel Discussion Central Room C Jack Wallace, Research Fellow, Australian Research Centre in Sex, Health and Society, Australia Enaam Oudih, Practice Manager, Multicultural Services,Manager BBV programs, Manager Multicultural Gambling Health Service, Relationships Australia, SA, Australia Cindy Shannon, Pro-Vice-Chancellor, The University of Queensland, Australia Barbara Luisi, Manager, NSW Multicultural HIV and Hepatitis Service, NSW, Australia | 10:30am - 11:00am HCV DAA Imports Failing to Deliver Results: SVR12 outcomes for imported DAA;s in the NT. Room 5 Matthew Maddison, Hepatitis C Clinical Nurse Consultant, Royal Darwin Hospital, NT, Australia Presentation | 10:30am - 11:00am Hepatitis B vaccination in the era of elimination Room 6 Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia |
| | 10:10am - 10:20am Simplification of HCV Diagnostic Strategies Central Room A Tanya Applegate, Senior Lecturer, The Kirby Institute, UNSW, Australia | |||
| | 10:20am - 10:30am Health Promotion Interventions in A&TSI Central Room A Kerri-Anne Smith, Aboriginal Hepatitis C Health Promotion Officer, Western Sydney Local Health District, Needle and Syringe Program, Australia Carla Treloar, Professor, Centre for Social Research in Health, UNSW, Australia Presentation | |||
| | 10:30am - 10:40am Health Promotion Interventions in PWID Central Room A Christian Vega, Policy & Research Officer, AIVL, Canberra, Australia | |||
| | 10:40am - 11:00am Panel Discussion - Future Research Priorities for Understanding Strategies to Enhance the Hepatitis B and C Care Cascade in Australia Central Room A Andrew Hill, Senior Visiting Research Fellow, Pharmacology Department Liverpool University Lisa Maher, Program Head and NHMRC Senior Research Fellow, The Kirby Institute, UNSW, Australia Jason Grebely, Associate Professor, The Kirby Institute, UNSW, Australia Jennifer MacLachlan, Epidemiologist, WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, Australia Margaret Hellard, Professor, Burnet Institute, Melbourne, VIC, Australia Kerri-Anne Smith, Aboriginal Hepatitis C Health Promotion Officer, Western Sydney Local Health District, Needle and Syringe Program, Australia Christian Vega, Policy & Research Officer, AIVL, Canberra, Australia Tanya Applegate, Senior Lecturer, The Kirby Institute, UNSW, Australia | |||
| 11.00 am - 11.30 am | Morning Tea Exhibition Hall, Hall 1 | |||
| 11.30 am - 1.00 pm | Epidemiology, Public Health & Prevention - Improving access to testing and care Central Room A Chairperson: Annie Balcomb, General Practitioner, Prince St Medical Practice, Australia | Community & Social Research - On the Road to Elimination Central Room C Chairperson: Cindy Shannon, Pro-Vice-Chancellor, The University of Queensland, Australia Chairperson: Zoe Dodd, co-founder and Program Coordinator, Toronto Community Hep C Program, Toronto, Canada | Clinical - Hepatitis C Antiviral Therapy: Reaching out in the new Era Room 5 Chairperson: Barbara Leggett, Medical Specialist, Royal Brisbane and Womens Hospital, Australia Chairperson: Mary Fenech, Nurse, Queensland Health, Australia | Basic Science - Understanding HCV Transmission, Immunity and Diagnosis Room 6 Chairperson: Margaret Littlejohn, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia Chairperson: Scott Bowden, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia |
| 11:30 am - 11:45 am | Using a Knowledge Translation Approach to Increase Testing of Patients at Risk of Hepatitis B in a Primary Health Setting Central Room A Jacqui Richmond, Research Fellow / Clinical Nurse Consultant, La Trobe University / Melbourne Health, Australia | Advocacy for Universal Access to Hepatitis C Medicines Central Room C Helen Tyrrell, CEO, Hepatitis Australia, ACT, Australia | An Integrated Primary Health Care Service Is Effective at Retaining and Linking Marginalised Groups In Hepatitis C Care: A Study of The Kirketon Road Centre, Kings Cross Room 5 Rosie Gilliver, Projects Manager/Clinical Nurse Consultant , Kirketon Road Centre, Kings Cross, Sydney, Australia | Commitment to CD8+ T Cell Exhaustion and Loss of Memory T Cell Potential Develops during Primary Chronic HCV Infection Room 6 Mehdi Rasoli Pirozyan, PhD Student, University of New South Wales, Australia |
| 11:45 am - 12:00pm | Responding To Notifications of Unspecified Hepatitis B and C in Victoria Central Room A Nicole Romero, Epidemiologist, WHO Collaborating Centre for Viral Hepatitis, VIDRL, Doherty Institute, Australia | Implementing the Hepatitis C Cure: The Public Health Implications Central Room C Jack Wallace, Research Fellow, Australian Research Centre in Sex, Health and Society, Australia | The Dog at my Daclatasvir: Real Life Experiences Delivering Direct Acting Antivirals to Marginalised, Homeless, and Active Drug Users Room 5 Rebecca Lothian, Clinical nurse specialist and is the Hepatitis C Treatment Coordinator , Kirketon Road Centre | Refolding the Hepatitis C Virus E2 Glycoprotein to Enhance Immunogenicity Room 6 Lilian Phu, Research Assistant, Burnet Institute, Australia |
| 12:00 pm - 12:15 pm | Populating the Hepatitis C Testing, Care and Treatment Cascade among People who Inject Drugs in Australia Central Room A Lisa Maher, Program Head and NHMRC Senior Research Fellow, The Kirby Institute, UNSW, Australia | Relationships Matter: Social Capital Theory and the Delivery of Hepatitis C Treatment in Prison Central Room C Lise Lafferty, PhD Candidate, The Kirby Institute, UNSW, Australia | Treatment Uptake for Chronic Hepatitis C in Australia Following Availability of Interferon-Free Treatments Room 5 Behzad Hajari, Associate Lecturer, UNSW, Australia | Trends of Hepatitis C Virus Epidemic in Australia and North America in 20th Century: Back Projections from Molecular Epidemiology Room 6 Chaturaka Rodrigo, PhD Student, School of Medical Sciences, UNSW, Australia |
| 12:15 pm - 12:30 pm | The Cascade of Care for Chronic Hepatitis B, Australia, 2013-2014 Central Room A Jennifer MacLachlan, Epidemiologist, WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, Australia | Cairns Hep C Free by 2020 Central Room C Carla Gorton, HIV, Viral Hepatitis, Sexual Health Coordinator, Cairns Sexual Health Service, Australia | Recruitment and Follow-Up of People Who Inject Drugs into a Nurse-Led HCV Treatment Trial Room 5 Sally Von Bibra, Research Officer, Burnet Institute, Australia | Modelling the Effects of Targeted DAA Hepatitis C Virus Treatment Strategies Using a Molecular Transmission Network of People with Recent Infection Room 6 Sofia Bartlett, Postgraduate Research Candidate, The Kirby Institute, Australia |
| 12:30 pm - 12:45 pm | A Survey of Hepatitis C Management by Victorian General Practitioners Post Pharmaceutical Benefits Scheme Listing of Direct Acting Antiviral Therapy Central Room A Amanda Wade, NHMRC PhD Student, Burnet Institute and Monash University, Australia | Prevalence and Correlates of Hepatitis C among Attendees at New Zealand Needle Exchanges: Results of the 2013 Seroprevalence Survey Central Room C Geoff Noller, Director / Research Consultant, Substance Use and Policy Analysis, New Zealand | Curing Hepatitis C in General Practice: The First 60 Days Room 5 David Baker, General Practitioner, East Sydney Doctors, Australia | Hepatitis C Virus Core Antigen: A Simplified Treatment Monitoring Tool among those with Recent HCV Infection, Including for Post-Treatment Relapse Room 6 Tanya Applegate, Senior Lecturer, The Kirby Institute, UNSW, Australia |
| 12:45 pm - 1:00 pm | Discussion Central Room C | Prevalence of Antiviral Resistance in an Australian Hepatitis C Population Room 5 Mark Douglas, Associate Professor, University of Sydney, Australia | Hepatitis C Virus Core Antigen and Dried Blood Spots as Simplified Hepatitis C Virus Diagnostic Tools Room 6 Francois Lamoury, Research Officer, The Kirby Institute, UNSW, Australia | |
| 1:00 pm - 1:45 pm | Lunch Exhibition Hall, Hall 1 | |||
| 1:45 pm - 2:30 pm | Closing Plenary: Panel Discussion - You can't ask that! Aus vs NZ: Who will win the elimination race? Central Room A Carla Treloar, Professor, Centre for Social Research in Health, UNSW, Australia Ed Gane, Professor of Medicine, University of Auckland, New Zealand Moderator: Zoe Dodd, co-founder and Program Coordinator, Toronto Community Hep C Program, Toronto, Canada Moderator: Andrew Hill, Senior Visiting Research Fellow, Pharmacology Department Liverpool University Susan Hay, Acting Chief Executive Officer, The Hepatitis Foundation of NZ,New Zealand Michael Wilson, Programme Manager, Northern Region Hepatitis C Programme, Northern Regional Alliance Limited, New Zealand Stuart Loveday, Chief Executive Officer , Hepatitis NSW, Australia Joanne Morgan, Australian Hepatology Association & Royal Adelaide Hospital, Adelaide, Australia | |||
| 2:30pm - 2:45 pm | Closing Remarks Central Room C Benjamin Cowie, Associate Professor, Doherty Institute, Melbourne, Australia | |||
| 2:45 pm - 2:45 pm | Conference Close | |||
